Clin2
NCT06786078Possibly a fitRecruiting

Lily Device trial to reduce hair loss during chemo

Chemotherapy Induced Alopecia

Part of Cancer, Skin clinical trials.

This trial tests a device called Lily that you wear during and after chemotherapy to help prevent hair loss. It's for people with breast cancer who are about to start specific types of chemo.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
85 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older with stage 1, 2, or 3 breast cancer and haven't started chemo yet.
  • You will receive one of the listed chemo regimens, like doxorubicin and cyclophosphamide, or paclitaxel, or docetaxel.
  • Your treatment plan includes at least 4 cycles of chemo and will be completed within 12 months.
  • You can wear the Lily device during chemo and for 2 to 4 hours after each session.
  • You do not have any hair loss or scalp conditions, and you have not used scalp cooling devices recently.
  • You are not pregnant and do not have other serious medical issues that could interfere.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05177289Recruiting
Light therapy to prevent hair loss during chemotherapy

This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.

Hasselt, Limburg
NCT07594678Not yet recruiting· Phase 2
Minoxidil and red-light therapy for chemotherapy hair loss

This study tests whether using minoxidil (a hair regrowth lotion) alone or with a low-level red-light therapy cap can help breast cancer patients regrow hair after chemotherapy. It aims to find a safe and effective way to improve hair regrowth after treatment.

Columbus, Ohio
NCT04986579Recruiting· Phase 2
Scalp cooling to reduce hair loss during breast cancer chemotherapy

This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.

Boston, Massachusetts
NCT06762548Not yet recruiting· Phase 3
Scalp treatment to prevent hair loss from chemotherapy for early breast cancer

This study tests a product called DA-007 applied to the scalp to help prevent hair loss caused by chemotherapy. It is for people with early-stage breast cancer who are about to start certain types of chemotherapy.

Rome
NCT07397325Recruiting· Phase 1/Phase 2
Study of a cooling cap to prevent hair loss from chemo

This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.

Manaus
NCT05484973Recruiting
Portable scalp cooling to help prevent chemotherapy hair loss

This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.

Tucson, Arizona

Hear when a new Chemotherapy Induced Alopecia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.